CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CT ORDER Other Confidential Order
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · New debt or obligation
- S-3 Offering Registration Statement
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 11,900 shares at an average $4.11 ($48,894)
- 4 Open-market buy Chief Executive Officer bought 18,400 shares at an average $4.36 ($80,228)
- 4 Open-market buy 10% owner bought 18,400 shares at an average $4.36 ($80,228)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- POS AM Other Post-effective Amendment for Registration Statement
Page 28 of 49 · 965 filings